Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedA banner announces NIH website transition updates and says both “Super Intelligence” and “Artificial Intelligence” may appear across NIH content during the transition.SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check35 days agoChange DetectedA new page revision label (Revision: v3.7.0) is added, and several sponsor/organization and document-related blocks are removed from the study record, indicating a cleanup of header and metadata rather than substantive content changes.SummaryDifference18%

- Check57 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates an update to the study page or template version rather than to any trial content.SummaryDifference0.0%

- Check64 days agoChange DetectedThe study record now shows the trial as Completed and adds a publication on HRQOL and symptom impact in CheckMate 9ER.SummaryDifference0.2%

- Check78 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, signaling a small editorial update rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.